Cargando…

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth

BACKGROUND: Ferroptosis is a unique cell death, dependent on iron and phospholipid peroxidation, involved in massive processes of physiopathology. Tremendous attention has been caught in oncology, particularly for those therapy-resistant cancers in the mesenchymal state prone to metastasis due to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongting, Zhang, Meng, Zhang, Jinghua, Sun, Zichen, Zhang, Wenxin, Dong, Weichen, Cheng, Chen, Yao, Yongzhong, Li, Kuanyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182687/ https://www.ncbi.nlm.nih.gov/pubmed/37179385 http://dx.doi.org/10.1186/s13578-023-01044-0

Ejemplares similares

Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration
por: Jin, Xueyang, et al.
Publicado: (2021)

Mammalian mitochondrial iron–sulfur cluster biogenesis and transfer and related human diseases
por: Zhang, Wenxin, et al.
Publicado: (2021)

Evaluation of Antibacterial Activity Expression of the Hinokitiol/Cyclodextrin Complex Against Bacteria
por: Inoue, Yutaka, et al.
Publicado: (2020)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

Hinokitiol inhibits Aspergillus fumigatus by interfering with the cell membrane and cell wall
por: Meng, Fanyue, et al.
Publicado: (2023)

Cur@SF NPs alleviate Friedreich’s ataxia in a mouse model through synergistic iron chelation and antioxidation
por: Xu, Li, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol
por: Tao, Xuan, et al.
Publicado: (2022)

Hinokitiol Negatively Regulates Immune Responses through Cell Cycle Arrest in Concanavalin A-Activated Lymphocytes
por: Chung, Chi-Li, et al.
Publicado: (2015)

Simvastatin induced ferroptosis for triple-negative breast cancer therapy
por: Yao, Xianxian, et al.
Publicado: (2021)

New therapeutic strategy of hinokitiol in haemorrhagic shock‐induced liver injury
por: Lu, Wan‐Jung, et al.
Publicado: (2018)

Hinokitiol Selectively Enhances the Antibacterial Activity of Tetracyclines against Staphylococcus aureus
por: Le, Chun-Yan, et al.
Publicado: (2023)

PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis
por: Wang, Zhe, et al.
Publicado: (2023)

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species
por: Kim, Dae Jin, et al.
Publicado: (2017)

Hinokitiol Protects Cardiomyocyte from Oxidative Damage by Inhibiting GSK3β-Mediated Autophagy
por: Xiao, Hongkai, et al.
Publicado: (2022)

Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits
por: Wu, Jing, et al.
Publicado: (2020)

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
por: Yu, Mengyu, et al.
Publicado: (2019)

Iron Metabolism and Ferroptosis in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2020)

Hinokitiol, a Natural Tropolone Derivative, Offers Neuroprotection from Thromboembolic Stroke In Vivo
por: Jayakumar, Thanasekaran, et al.
Publicado: (2013)

Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model
por: Isono, Toshihito, et al.
Publicado: (2020)

AMPK Activation Mediated by Hinokitiol Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells through Autophagy Flux
por: Lee, Ju-Hee, et al.
Publicado: (2018)

Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells
por: Seo, Jung Seon, et al.
Publicado: (2017)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

Effects of Hinokitiol and Dicalcium Phosphate on the Osteoconduction and Antibacterial Activity of Gelatin-Hyaluronic Acid Crosslinked Hydrogel Membrane In Vitro
por: Chang, Kai-Chi, et al.
Publicado: (2021)

Stimulation of Hepatic Ferritinophagy Mitigates Irp2 Depletion-Induced Anemia
por: Liu, Yutong, et al.
Publicado: (2023)

Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines
por: Yang, Shun-Cheng, et al.
Publicado: (2022)

Hinokitiol for hypertensive emergencies: effects on peripheral resistance, cardiac load, baroreflex sensitivity, and electrolytes balance
por: Omar, Hoda A., et al.
Publicado: (2023)

Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
por: Chen, Hsin-Chih, et al.
Publicado: (2022)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
por: Xu, Shuo, et al.
Publicado: (2023)

Iron Metabolism in Ferroptosis
por: Chen, Xin, et al.
Publicado: (2020)

Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
por: Yan, Nao, et al.
Publicado: (2020)

Hinokitiol impedes tumor drug resistance by suppressing protein kinase B/mammalian targets of rapamycin axis
por: Ni, Ying-Jui, et al.
Publicado: (2022)

Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug
por: Camaioni, Louis, et al.
Publicado: (2023)

Iron Metabolism and Ferroptosis in Physiological and Pathological Pregnancy
por: Zhang, Yijun, et al.
Publicado: (2022)

Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells
por: Tsao, Yu-Tzu, et al.
Publicado: (2016)

Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis
por: Jayakumar, Thanasekaran, et al.
Publicado: (2018)

Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway
por: Wu, Yueh-Jung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_juee3rifvn3vqo6d2j6ebbsq4u